Business
TABUK LAUNCHES VIBATIV® FDA-APPROVED ANTIBIOTIC WITH LIFE-SAVING POTENTIAL IN SAUDI ARABIA
Specialty pharmaceutical companies Tabuk Pharmaceutical Manufacturing Company a fully owned subsidiary of Astra Industrial Group and a leading pharmaceutical company in the Middle East and Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, today announced the launch of Cumberland's Vibativ® (telavancin) injection in Saudi Arabia.
About this update from Cumberland Pharmaceuticals Inc.
[{"type":"text","content":"Vibativ ® treats patients with pneumonia and serious skin infections","length":74,"tagName":"p","attribs":{}},{"type":"text","content":"NASHVILLE, Tenn. and RIYADH, Saudi Arabia, Sept. 29, 2025 /PRNewswire/ -- Specialty pharmaceutical companies Tabuk Pharmaceutical Manufacturing Company a fully owned subsidiary of Astra Industrial Group and a leading pharmaceutical company in the Middle East and Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, today announced the launch of Cumberland's Vibativ® (telavancin) injection in Saudi Arabia.","length":442,"tagName":"p"},{"type":"image","alt":"Tabuk Pharmaceutical Manufacturing Company and Cumberland Pharmaceuticals Inc. announced the launch of Cumberland’s Vibativ® (telavancin) injection in Saudi Arabia.","displaySize":"","headline":null,"caption":"Tabuk Pharmaceutical Manufacturing Company and Cumberland Pharmaceuticals Inc. announced the launch of Cumberland’s Vibativ® (telavancin) injection in Saudi Arabia.","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":129,"url":"https://media.zenfs.com/en/prnewswire.com/ffdd6b3acf9906ceb33ed54ffbcf16bd"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/l3TamNzyoICOUA20bSEwPw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTIyNztjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/ffdd6b3acf9906ceb33ed54ffbcf16bd","width":400,"height":129}},"href":"https://mma.prnewswire.com/media/2783511/Tabuk.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The announcement follows an agreement between the companies providing Tabuk with the exclusive rights to register and promote the product for patients in Saudi Arabia and other countries in the Middle East.","length":211,"tagName":"p"},{"type":"text","content":"Vibativ is a patented, FDA-approved injectable anti-infective that can serve as a potentially life-saving treatment in patients with hospital-acquired and ventilator-associated pneumonia resulting from infections, including the flu and COVID-19. It is intravenously administered with once-daily dosing and does not require therapeutic drug monitoring, decreasing health care professionals' exposure to the patient. It is designed to treat serious infections due to Staphylococcus aureus (S. aureus) and other Gram-positive bacteria, including Met...